Immunotherapy in Thyroid Cancer: Current Strategies and Challenges
Checkpoint immunotherapies offer hope for advanced thyroid cancer, though overcoming tumor resistance remains a significant clinical challenge.
This review covers the current landscape of immunotherapy in thyroid cancer, highlighting checkpoint inhibitors and combination strategies for advanced anaplastic thyroid carcinoma. The field remains challenging due to tumor heterogeneity and immune evasion mechanisms.
What the study was
- Study design
- Narrative review
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Cancer medicine
Why it surfaced
Standard narrative review of known strategies; limited novelty.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.